Here’s whether TG Therapeutics, Inc. (TGTX) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.88% over 10 days); strong 1-year return of +88.6%; 3-month momentum positive (+39.6%). Concerns: RSI 75 — overbought, elevated pullback risk. Currently 8.5% off its 52-week high. Score: +5/7.
TGTX is in a confirmed uptrend, trading above both its 50-day ($52.85) and 200-day ($37.83) moving averages. With an RSI of 75.1, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +88.6% compares to +20.5% for SPY (beat the market by 68.2%).
$10,000 invested 1 year ago→ $18,863 today
vs. S&P 500 (SPY) — same period beat market by 68.2%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($37.83)
✓Above 50-day MA ($52.85)
!RSI(14) neutral zone (30–70) — currently 75.1
✓Positive return (+88.6%)
✓Within 10% of period high (−8.5%)
Period Range $54.27
$26.76$59.30
RSI (14) 75.1
0 · OversoldOverbought · 100
Key Metrics
Price$54.27
Period Return+88.6%
Period High$59.30
Period Low$26.76
Drawdown−8.5%
MA-50$52.85
MA-200$37.83
RSI (14)75.1
Avg Volume (30d)2.3M
vs. SPYbeat by 68.2%
Return Rank#141 of 999
Trend Signals
Price is above the 200-day moving average ($37.83)